Luigi Mangione Confesses to Shooting UnitedHealthcare CEO Brian Thompson: ‘I Shot Mr. Thompson’ - Internewscast Journal
Luigi Mangione Confesses to Shooting UnitedHealthcare CEO Brian Thompson: ‘I Shot Mr. Thompson’

Topline

Luigi Mangione pleaded guilty Friday to federal stalking charges tied to the alleged killing of UnitedHealth CEO Brian Thompson, acknowledging in court that he “shot” Thompson and sidestepping a federal trial that had been scheduled for January. Whether that plea will affect his separate New York state trial set for next month remains uncertain.

Key Facts

Mangione formally entered the plea during a Friday morning hearing in Manhattan, responding “yes” when the judge asked whether he intended to admit guilt to the federal charges.

The 28-year-old admitted to two federal stalking counts connected to Thompson’s death, after more severe murder charges—charges that could have made him eligible for the death penalty—were previously dismissed by the court. Mangione had originally pleaded not guilty to all charges.

Reading from a statement in court, Mangione accepted responsibility, telling the judge, “I shot Mr. Thompson in Manhattan,” and adding that he “knew what I was doing was illegal.”

The guilty plea was not part of a negotiated agreement with prosecutors. Judge Margaret Garnett is expected to sentence Mangione in December.

He faces a maximum sentence of life in prison after pleading guilty, Judge Margaret Garnett said Friday, and would have to serve at least 85% of his sentence before being released for good behavior—also noting any sentence he faces in his state case could be added to his federal punishment.

Mangione was asked a series of questions by the court about his mental state and whether it was altered in any way as he pleads guilty—answering, “I do,” when asked if he feels “his mind is clear today”—and Garnett said the suspect appeared “fully competent” to enter the plea.

Mangione’s defense team is expected to point to the federal plea as part of an effort to derail his separate New York state trial, likely arguing that double jeopardy protections should prevent him from being prosecuted twice over the same alleged crime. State prosecutors are expected to oppose that claim, and it is not yet clear whether the argument will succeed.

What Happened At The Hearing?

Mangione appeared in court and the judge said the suspect was expected to plead guilty. Garnett then asked Mangione a series of questions by the court about his mental state and whether it was altered in any way as he pleads guilty, with him answering, “I do,” when asked if he feels “his mind is clear today.” The judge said the suspect appeared “fully competent” to enter the plea, before asking whether he accepted that he was giving up his rights to a fair trial and faced a potential sentence of life imprisonment. He then read the statement admitting his guilt, describing how he traveled to New York City and posed as an investor to find out information about UnitedHealthcare’s annual investor conference, and printed a firearm using a 3-D printer that he then used to shoot Thompson.

What to Watch for

Mangione’s trial in state court is still set to begin with jury selection Sept. 8, though any plea in federal court is likely to lead to a flurry of requests seeking to fend off that trial. The suspect also faces a sentence of life in prison if convicted of second-degree murder at the state trial, as New York does not have the death penalty.

Will Mangione’s State Trial Still Take Place?

While the U.S. Supreme Court has broadly allowed people to be prosecuted in both state and federal court for the same crime, New York has a stronger law against “double jeopardy” prosecutions. The state generally forbids prosecuting people twice for the same crime, but there are a few exceptions. Multiple prosecutions are allowed if each prosecution “contains an element which is not an element of the other,” for instance, or if “the acts establishing one offense are in the main clearly distinguishable from those establishing the other.” That means state prosecutors could try to argue that the state charges against Mangione, which include murder and possession of a weapon, are materially different from the stalking charges he pleaded guilty to in federal court. Whether or not that will be successful remains to be seen, with the Times noting prosecutors have previously both failed and succeeded at bringing charges in the past. “It is incredibly complicated,” defense attorney Paul Shechtman told the Times earlier in August about New York’s law.

Key Background

Mangione was arrested in December 2024 following a dayslong manhunt, after Thompson was shot on the streets of midtown Manhattan in the early morning of Dec. 2. The suspect was arrested at a McDonald’s in Altoona, Pennsylvania, and was found with an alleged “manifesto” that railed against corporate greed and the U.S. healthcare industry. Mangione’s case has garnered widespread attention and the suspect has attracted some support amid Americans’ growing disillusionment with rising healthcare costs. The Justice Department initially sought the death penalty against Mangione, bringing charges for murder through use of a firearm and use of a firearm with a silencer to commit a “crime of violence.” Former Attorney General Pam Bondi said she had directed prosecutors to pursue the death penalty “after careful consideration,” citing President Donald Trump’s “agenda to stop violent crime and Make America Safe Again.” The court threw out those charges in January, however, ruling Mangione could only face those charges if the other federal charges he faced are considered “crimes of violence” under federal law, which they are not. His guilty plea Friday took place after Mangione was previously reportedly in talks to reach a deal in June, but negotiations fell through and the deal never came to pass.

This story is breaking and will be updated.

Further Reading

Luigi Mangione Won’t Face Death Penalty As Judge Throws Out Two Charges (Forbes)

Luigi Mangione Trial Starts Next Month—Here’s What To Expect (Forbes)

Leave a Reply

Your email address will not be published. Required fields are marked *